We conducted a systematic reiew and meta-analysis to substantiate the alidity and releance of this contention. 我們運用系統評價和匯總分析的方法來證明此論點的有效性和相關性。
Primary economic evaluations are needed in the case that the systematic review of existing economic evidence is not capable of informing economic profiles of marketed medicines. 摘要當現有經濟學證據的系統評價不能充分評價上市后藥物的經濟學情況時,需要開展原始的經濟學評價研究。